Related references
Note: Only part of the references are listed.Suppressing physiologic 18-fluorodeoxyglucose uptake in patients undergoing positron emission tomography for cardiac sarcoidosis: The effect of a structured patient preparation protocol
Georgios Christopoulos et al.
JOURNAL OF NUCLEAR CARDIOLOGY (2021)
A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology
Riemer H. J. A. Slart et al.
JOURNAL OF NUCLEAR CARDIOLOGY (2018)
Efficacy and safety of infliximab biosimilar Inflectra® in severe sarcoidosis
Milou C. Schimmelpennink et al.
RESPIRATORY MEDICINE (2018)
Prognostic Impact of Extent, Severity, and Heterogeneity of Abnormalities on 18F-FDG PET Scans for Suspected Cardiac Sarcoidosis
Brett W. Sperry et al.
JACC-CARDIOVASCULAR IMAGING (2018)
Pulmonary sarcoidosis
Paolo Spagnolo et al.
LANCET RESPIRATORY MEDICINE (2018)
Repository corticotropin for Chronic Pulmonary Sarcoidosis
Robert P. Baughman et al.
LUNG (2017)
Clinical characteristics of patients with bone sarcoidosis
Ying Zhou et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2017)
Comparative evaluation of 18F-FLT and 18F-FDG for detecting cardiac and extra-cardiac thoracic involvement in patients with newly diagnosed sarcoidosis
Takashi Norikane et al.
EJNMMI RESEARCH (2017)
Additional Heparin Preadministration Improves Cardiac Glucose Metabolism Suppression over Low-Carbohydrate Diet Alone in 18F-FDG PET Imaging
Asbjorn M. Scholtens et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
F-18-Fluorodeoxyglucose Positron Emission Tomography-Guided Sampling of Mediastinal Lymph Nodes in the Diagnosis of Cardiac Sarcoidosis
Piia Simonen et al.
AMERICAN JOURNAL OF CARDIOLOGY (2015)
Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis
Adriane D. M. Vorselaars et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
New treatment strategies for pulmonary sarcoidosis: antimetabolites, biological drugs, and other treatment approaches
Robert P. Baughman et al.
LANCET RESPIRATORY MEDICINE (2015)
Dual-Time Point Whole-Body 18F-Fluorodeoxyglucose PET/CT Imaging in Undiagnosed Mediastinal Lymphadenopathy A Prospective Study of 117 Patients With Sarcoidosis and TB
Venkata Nagarjuna Maturu et al.
CHEST (2014)
Ocular Sarcoidosis Does 18F-FDG PET/CT Have Any Role?
Rayamajhi Sampanna Jung et al.
CLINICAL NUCLEAR MEDICINE (2014)
SPLENIC SARCOIDOSIS WITHOUT FOCAL NODULARITY: A CASE OF 1,25-DIHYDROXYVITAMIN D-MEDIATED HYPERCALCEMIA LOCALIZED WITH FDG PET/CT
Benjamin A. Dennis et al.
ENDOCRINE PRACTICE (2014)
Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis
Michael T. Osborne et al.
JOURNAL OF NUCLEAR CARDIOLOGY (2014)
Cardiac Positron Emission Tomography Enhances Prognostic Assessments of Patients With Suspected Cardiac Sarcoidosis
Ron Blankstein et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
FDG PET for Gauging of Sarcoid Disease Activity
Human Adams et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Utility of FDG-PET-CT scanning in assessing the extent o disease activity and response to treatment in sarcoidosis
Randeep Guleria et al.
LUNG INDIA (2014)
18F-FDG PET/CT Imaging of Extensive Systemic Sarcoidosis With Epididymal Involvement
Fumitoshi Aga et al.
CLINICAL NUCLEAR MEDICINE (2013)
Muscular Sarcoidosis Detected by F-18 FDG PET/CT in a Hypercalcemic Patient
Eun Ji Han et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2013)
Severity of pulmonary involvement and 18F-FDG PET activity in sarcoidosis
Remy L. M. Mostard et al.
RESPIRATORY MEDICINE (2013)
Intraocular sarcoidosis: association of clinical characteristics of uveitis with findings from 18F-labelled fluorodeoxyglucose positron emission tomography
Ahmed Rahmi et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2012)
F-18 FDG PET/CT for Detecting Bone and Bone Marrow Involvement in Sarcoidosis Patients
Remy L. Mostard et al.
CLINICAL NUCLEAR MEDICINE (2012)
The value of [18F]-fluorodeoxyglucose-positron emission tomography/CT scanning in the diagnosis of neurosarcoidosis
M. Meenakshi et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2012)
The Use of 18F-FDG PET in the Diagnosis of Cardiac Sarcoidosis: A Systematic Review and Metaanalysis Including the Ontario Experience
George Youssef et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
The Utility of 18F-FDG PET/CT for Diagnosis and Adjustment of Therapy in Patients with Active Chronic Sarcoidosis
Dragana Sobic-Saranovic et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis
R. L. M. Mostard et al.
RESPIRATORY MEDICINE (2011)
18F-FDG PET patterns and BAL cell profiles in pulmonary sarcoidosis
Ruth G. Keijsers et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Fluorine-18 Fluorodeoxyglucose with Positron Emission Tomography Revealed Bone Marrow Involvement in Sarcoidosis Patients with Anaemia
Nicolas de Prost et al.
RESPIRATION (2010)
18F-FDG PET, genotype-corrected ACE and sIL-2R in newly diagnosed sarcoidosis
Ruth G. Keijsers et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
18F-FDG PET successfully detects spinal cord sarcoidosis
Kiyobumi Ota et al.
JOURNAL OF NEUROLOGY (2009)
Fluorodeoxyglucose positron emission tomography (FDG-PET) is useful in the diagnosis of neurosarcoidosis
Seza Bolat et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Early 2'-Deoxy-2'-[18F]Fluoro-d-Glucose PET Metabolic Response after Corticosteroid Therapy to Differentiate Cancer from Sarcoidosis and Sarcoid-like Lesions
Nicolas Aide et al.
MOLECULAR IMAGING AND BIOLOGY (2009)
Fluorodeoxyglucose Positron Emission Tomography for the Diagnosis of Sarcoidosis in Patients with Unexplained Chronic Uveitis
Pascal Seve et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2009)
The many faces of sarcoidosis: asymptomatic muscle mass mimicking giant-cell tumor
Likurgos Kolilekas et al.
RHEUMATOLOGY INTERNATIONAL (2009)
Laryngeal Sarcoidosis Detected by FDG Positron Emission Tomography
Kyoichi Kaira et al.
CLINICAL NUCLEAR MEDICINE (2008)
18F-FDG PET/CT in sarcoidosis management:: review and report of 20 cases
Jean Jacques Braun et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Comparison of F-18-FDG and Ga-67-citrate in sarcoidosis imaging
E. Prager et al.
NUKLEARMEDIZIN-NUCLEAR MEDICINE (2008)
Use of whole-body FDG PET-CT to aid in the diagnosis of occult sarcoidosis
Bradford L. Tannen et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2008)
Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis
Alvin S. Teirtein et al.
CHEST (2007)
Extensive FDG uptake and its modification with corticosteroid in a granuloma rat model: an experimental study for differentiating granuloma from tumors
Songji Zhao et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Potential biomarkers for diagnosis of sarcoidosis using proteomics in serum
Judith A. Bons et al.
RESPIRATORY MEDICINE (2007)
Diagnostic usefulness of fluorine-18-α-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients
Kyoichi Kaira et al.
CHEST (2007)
Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation
YC Fu et al.
BLOOD CELLS MOLECULES AND DISEASES (2004)
Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis
S Rothkrantz-Kos et al.
CLINICAL CHEMISTRY (2003)
Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis - A clinical evaluation
JC Grutters et al.
CHEST (2003)